Targeting CD19 in Diffuse Large B-Cell Lymphoma

May 7, 2020
Targeted Oncology

Experts in the management of diffuse large B-cell lymphoma (DLBCL) discuss the use of novel CD19-antibody mono- and combination therapies to treat relapsed/refractory subpopulations.